Identifying the mechanisms that determine CMV latency could lead to targeted therapies that prevent CMV-related disease.Continue reading
Author Archive: AZBio
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, announced it has expanded its exclusive license agreement for certain biomarker and autoantibody technologies identified by researchers Joshua LaBaer, M.D., Ph.D. and Karen Anderson, M.D., Ph.D. of the Biodesign Institute of Arizona State University. The license provides Provista with access to patents, proprietary technology, materials, processing techniques and protocols necessary for detection of certain autoantibodies and use of certain biomarkers. Continue reading
Moving Up
In January 2013 at TEDx Beacon Street, Harvard Business School’s Rosabeth Moss Kanter shared Six Keys to Leading Positive Change. Let’s look at how can we apply them to grow our Bioscience and Healthcare Industry here in Arizona so we can individually and collectively keep things moving up.Continue reading
Job Alert: Join ASU’s Entrepreneurship & Innovation Team
Exciting employment opportunities are currently available with the Entrepreneurship & Innovation (EI) Team at ASU. Continue reading
DNA nanotechnology places enzyme catalysis within an arm’s length
Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.Continue reading
Organizational Changes Strengthen and Expand Celgene Leadership Team
Celgene Corporation (CELG) today announced organizational changes that will go into effect on August 1, 2014.Continue reading
Ventana Companion Diagnostics CAP/CLIA lab launches new Robust Prototype Assays
New diagnostic tests offer pharma and biotech companies more options for targeting cancer in research studies
Yulex CEO Jeff Martin Named Ernst & Young Entrepreneur Of The Year Finalist
Jeff Martin, co-founder and CEO of Yulex, has been named a finalist for the Ernst & Young (EY) Entrepreneur Of The Year 2014 Award in the Mountain Desert region. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.Continue reading
1,300th Implant of the SynCardia Total Artificial Heart Was Performed in April 2014
When All Other Treatments Fail, the SynCardia Total Artificial Heart Can Save the Sickest of the Sick. The Freedom Portable Driver Allows a Majority of SynCardia Patients to be Discharged from the Hospital to Live at Home & Get In Better Shape for Their Heart Transplant.Continue reading
Mission3 to Provide Thought Leadership and Expertise at DIA 2014
Phoenix, AZ – May 19, 2014 – Mission3, Inc., a Premier Regulatory Information Management provider for the Life Sciences industry, will be exhibiting at DIA 2014 in San Diego, CA, June 15-19. Both Dirk Beth, Managing Director of Mission3, and Adair Turner, Director of Professional Services at Mission3, will be featured presenters in the continuing education program of the Conference.Continue reading